<span style="font-variant: small-caps">l</span>-Arginine and COVID-19: An Update

par Ayobami Adebayo, Fahimeh Varzideh, Scott Wilson, Jessica Gambardella, Michael Eacobacci, Stanislovas S. Jankauskas, Kwame Donkor, Urna Kansakar, Valentina Trimarco, Pasquale Mone, Angela Lombardi, Gaetano Santulli
Publié 2021

The beneficial impact of filtration surgery on antiviral therapy cessation in patients with cytomegalovirus-related secondary glaucoma

par Yusuke Murai, Sotaro Mori, Fumio Takano, Kaori Ueda, Mari Sakamoto, Takuji Kurimoto, Sentaro Kusuhara, Yuko Yamada-Nakanishi, Makoto Nakamura
Publié 2021

Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects

par Erika Schlaepfer, Audrey Fahrny, Maarja Gruenbach, Stefan P. Kuster, Viviana Simon, Gideon Schreiber, Roberto F. Speck
Publié 2019

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2

par Qilong Tang, Raymond J. Owens, James H. Naismith
Publié 2021

COVID-19 therapy: from myths to reality and hopes

par S. V. Bozrova, M. S. Drutskaya, S. A. Nedospasov
Publié 2020

Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection

par I.G. Gaiduchok, Kh.O. Lishchuk-Yakymovych
Publié 2020

Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China

par Min Li, PhD, Lianhui Zhao, MD, Jialing Zhou, MSc, Yameng Sun, MD, Xiaoning Wu, MD, Xiaojuan Ou, MD, Hong You, MD, Yuanyuan Kong, PhD, Jidong Jia, MD
Publié 2021

EFFICIENCY OF IMMUNOCORRECTION IN СHRONIC VIRAL HEPATITIS C PATIENTS TREATED BY ANTIVIRALS

par L. P. Sklyar, E. V. Markelova, I. S. Gorelova
Publié 2014

FeLV-infection: problems and prospects of vaccine prevention and interferon-therapy of feline leukemia

par T. V. Moskvina, M. Yu. Shchelkanov, A. V. Tsybulski
Publié 2021

THE IMMUNE STATUS AND IFN GENE POLYMORPHISM AS PROGNOSTIC CRITERIA FOR THE EFFECTIVENESS OF HEPATITIS C TREATMENT IN HIV-INFECTED PATIENTS

par E. S. Kovaleva, B. Yu. Gumilevsky
Publié 2014

DIAGNOSTIC VALUE OF IMMUNOLOGICAL EXAMINATION IN SPECIFYING A ROLE OF HERPESVIRUS INFECTION IN DEVELOPMENT OF HEMORRHAGIC VASCULITIS WITH RENAL IMPAIRMENT

par R. A. Belovolova, L. V. Mavrina, G. M. Letifov, L. F. Ovsyannikova, N. V. Selutin, M. Yu. Ovsyannikova
Publié 2014

The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study

par Yi Li, Yiwei Xiao, Lili Li, Yarong Song, Xiangjun Zhai, Jianxun Liu, Zhongping Duan, Ling Yan, Feng Ding, Jia Liu, Liguo Zhu, Jie Jiang, Huaibin Zou, Lingxiang Li, Caihong Liang, Jie Wang, Jie Li
Publié 2021

The need for area under the curve measurements in the field of ganciclovir therapeutic drug monitoring in children: a case report

par Xavier Duval, Florian Lemaitre, Sophie Pertuisel, Jamie Probert, Virginie Gandemer, Marie-Clémence Verdier, Camille Tron
Publié 2021

СHROMOSOMALLY INTEGRATED HUMAN HERPESVIRUS 6

par M. A. Nikolskiy, V. S. Golubcova
Publié 2015

Clinical characteristics of patients with COVID-19 depending on the treatment received and the presence of type 2 diabetes mellitus

par K. G. Lobanova, T. Y. Demidova, S. N. Perekhodov, M. B. Antsiferov
Publié 2021

EXPRESSION PATTERNS OF CHEMOKINE RECEPTORS CXCR3 AND CCR6, AND THEIR LIGANDS IN PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC HEPATITIS C DURING ANTIVIRAL THERAPY USING PEGYLATED IN...

par V. V. Basina, N. A. Arsentieva, O. K. Batsunov, N. E. Lyubimova, A. V. Semenov, E. V. Esaulenko, Areg A. Totolian
Publié 2019